Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Operational Other
confidence 75%
filed 2026-06-18
EX-99.1
Clearmind announced the grant of U.S. Patent No. 12,350,242 for "Binge Behavior Regulators" covering its molecule MEAI, bringing its total granted patent portfolio to 32 patents across 19 families. For a clinical-stage biotech company, patent grants are operationally significant milestones that strengthen IP protection for lead candidates like CMND-100 and support competitive positioning in psychedelic-based therapeutics. While not a specific named event type, this is a material operational/strategic disclosure affecting the company's intellectual property position and development pipeline.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-18
Item 7.01
This Item 7.01 disclosure announces an updated investor presentation posted to the company's website on June 17, 2026. The presentation contains material forward-looking statements regarding the pending Canyon Creek acquisition, anticipated dividend increases from $1.35 to $1.50 per share post-close, a $1.0Bn Goldman Sachs ABS Warehouse Facility, and a $15Bn acquisition pipeline. While the presentation itself is furnished (not filed) under Regulation FD, the substantive disclosures—particularly the acquisition economics, financing arrangements, and dividend guidance—constitute material updates to investors about the company's strategic direction and financial outlook. This does not fit neatly into the more specific event categories (it is not an earnings release, M&A completion, or compensation arrangement), but the forward-looking guidance and acquisition-related disclosures are material to a reasonable investor's assessment of the registrant.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 75%
filed 2026-06-18
EX-99.1
The exhibit announces a share repurchase program approved by TGE's Board of Directors authorizing repurchases of up to US$10 million of ordinary shares, which constitutes a return of capital to shareholders. While the announcement also includes a voluntary lock-up commitment by the controlling shareholder (AMTD Digital Inc.) and management, the primary disclosed action is the share repurchase authorization, which falls under dividend_distribution as a capital return mechanism. The repurchase is material as it signals board confidence in valuation and affects shareholder value.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-06-18
EX-99.1
Megan Holdings Ltd. disclosed a proxy statement and notice of annual general meeting scheduled for July 13, 2026, seeking shareholder approval for three proposals: (1) authorization for a share consolidation (up to 1-for-400) to address Nasdaq minimum bid price requirements, (2) amendments to the memorandum and articles of association to shorten meeting notice periods and post-service timing, and (3) an adjournment proposal. The share consolidation is material as it directly addresses Nasdaq listing compliance and would significantly alter the company's share structure.
View raw filing on EDGAR →
6-K
M&A activity
confidence 85%
filed 2026-06-18
EX-99.1
NewGen has executed an agreement for a US$4 million strategic investment in K25.ai, completing a US$10 million Pre-A round and increasing NewGen's aggregate ownership to 10%. This represents a material acquisition of a significant equity stake in an external company, coupled with exclusive Asia-Pacific agency rights. The transaction is disclosed as a strategic milestone and would materially affect a reasonable investor's assessment of NewGen's capital deployment and portfolio composition.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-18
EX-99.1
Sagtec Global Limited issued 1,500,000 Class A Ordinary Shares to CEO and major shareholder Ng Chen Lok at US$1.04 per share (US$1.56 million aggregate) in a private placement of unregistered, restricted securities with no registration rights.
View raw filing on EDGAR →
6-K
Operational Other
confidence 72%
filed 2026-06-18
EX-99.2
Sagtec Global provided FY2026 financial guidance (35% revenue growth, 22% net profit growth), announced strategic expansion of its Malaya Heritage F&B business with four new outlet openings, and disclosed approximately US$3.0 million in secured project backlog expected to be recognized.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 75%
filed 2026-06-18
EX-99.1
The exhibit announces a share repurchase program approved by TGE's Board of Directors authorizing repurchases of up to US$10 million of ordinary shares. While the primary focus is the repurchase program, the announcement also discloses a voluntary lock-up commitment by the controlling shareholder (AMTD Digital Inc.), directors, and management for two years. Share repurchases are a form of capital return to shareholders and fall within the dividend_distribution category. The Board's stated rationale—that shares are "drastically undervalued" and the program is "intended to enhance shareholder value"—indicates material significance to investors assessing the company's capital allocation and management confidence.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-06-18
Item 8.01
Ondas Inc. entered into a definitive agreement to acquire Cyberhawk Holdings Limited in a material acquisition valued at approximately $125 million, structured as ~95% cash and 5% equity, with expected close in Q3 2026. The transaction expands Ondas into critical infrastructure intelligence with $45M+ expected revenue and $95M backlog.
View raw filing on EDGAR →
6-K
Exec departure
confidence 92%
filed 2026-06-18
Ms. Liu Liangping resigned from her position as Director of the Board effective immediately on June 18, 2026. Although she retains her COO role and other subsidiary positions, the departure from the Board constitutes a material executive departure. The stated reason—to devote herself to M&A projects—and the explicit statement that the resignation is not due to disagreement suggest an orderly transition, but Board-level departures are material to investors assessing governance and leadership continuity.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-06-18
EX-99.1
The press release announces that Luda Technology Group Limited has signed a memorandum of understanding (MOU) to acquire 55% shares in Asia AI Data Centre & Quantum Technology Company Limited for USD 400,000 in cash plus USD 535,000 in ordinary shares. This represents a material acquisition activity marking the company's strategic entry into the data centre and AI computing infrastructure industry, a significant diversification from its core stainless steel and carbon steel flanges business. The transaction involves a related party (Ms. Liu Liangping, the COO and spouse of CEO Mr. Ma Biu) and is explicitly characterized as transforming the company's data centre strategy "from exploration into execution."
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-18
Item 8.01
Cadrenal announced plans to submit a Rare Pediatric Disease Designation (RPDD) request to the FDA for tecarfarin in Kawasaki disease, which if granted would make the company eligible for a Priority Review Voucher valued at $180–$205 million. The company also disclosed a dual-track portfolio strategy representing a material strategic and regulatory development affecting investor expectations around value creation and capital efficiency.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-06-18
Lion Group Holding Ltd. entered into a Memorandum of Understanding on June 18, 2026, for the potential acquisition of 100% of Aquila Hash, Inc., a Delaware corporation. Although the MOU is non-binding except for customary provisions and contemplates future negotiation of definitive terms, the entry into a material acquisition agreement—even in preliminary form—is a reportable M&A activity event. The disclosure explicitly identifies this as a potential acquisition transaction and establishes a 60-day exclusivity and due diligence period, signaling serious intent and materiality to investors.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-18
Item 7.01
BiomX disclosed a strategic transition to a defense and security technology holding company and posted an updated investor presentation reflecting this repositioning. While Item 7.01 (Regulation FD Disclosure) is typically used for routine informational updates, the substance here—a completed "fundamental strategic transition" away from legacy clinical-stage biotech activities—is material to investors' understanding of the company's business model, portfolio, and strategy. The press release and presentation emphasize real deployments, customer relationships (Elbit Systems, Rafael), and a new operating framework (Detection-Analysis-Response), which would affect a reasonable investor's assessment. However, this does not fit neatly into the specific event-type taxonomy (not M&A, not an executive change, not a restatement or impairment), so "other_material" is most appropriate.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 8.01
The disclosure announces the commencement of separate trading of Class A Ordinary Shares and Warrants from Units following the Company's IPO completed on June 4, 2026. This is a routine post-IPO administrative event related to unit separation and listing mechanics. While it affects the trading structure of the Company's securities, it does not fit neatly into the more specific event categories (not an earnings release, executive change, M&A activity, impairment, covenant breach, or other defined material events). The event is material to investors as it affects how the Company's securities trade, but it is primarily a procedural/administrative disclosure rather than a substantive business or financial event.
View raw filing on EDGAR →
8-K
Covenant Breach
confidence 72%
filed 2026-06-18
MSP Recovery disclosed entry into a discretionary $0.1 million advance from Hazel Partners under an existing working capital facility on June 11-12, 2026. The filing emphasizes that the facility is entirely discretionary with no committed liquidity, no borrowing base, and no obligation to fund. Critically, the company explicitly states "no remaining funding capacity was available under the facility" as of Q3-2025, and this advance is a "one-time" accommodation that "does not reinstate, replenish, or otherwise reopen availability." The company's repeated cautions that this should not be viewed as indicative of future funding availability, combined with the exhaustion of prior capacity and reliance on discretionary advances for operating expenses, signals financial stress and potential covenant concerns or technical defaults that prompted Hazel's discretionary accommodation.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-18
EX-99.1
This is a monthly operational and production update disclosing material business metrics and strategic progress. The exhibit reports significant operational achievements: Bitcoin production of 921 BTC (up 370% Y/Y), self-mining hash rate of 70.2 EH/s, AI Cloud ARR of ~$69M at 90% utilization, and advancement of major infrastructure projects (Tydal, Norway colocation negotiations in "advanced stages," GB300 cluster deployment). These metrics and strategic milestones would affect a reasonable investor's assessment of the company's operational execution and growth trajectory, particularly given the company's focus on AI and Bitcoin mining infrastructure. While not fitting a specific named category (not earnings, not M&A, not a discrete event), the disclosure is clearly operational and material to the registrant's business performance.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 85%
filed 2026-06-18
Globavend entered into a Standby Equity Purchase Agreement (SEPA) on June 16, 2026, with YA II PN, Ltd. for the purchase of up to $20 million of ordinary shares over 36 months. This is a committed equity financing arrangement where the company can draw down capital by issuing shares at a discount to market price (93–96% of VWAP), subject to registration. The structure and mechanics—discretionary advances, volume-weighted pricing, and a $20 million commitment—are characteristic of a PIPE-like dilutive equity issuance used to raise capital.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-18
Item 5.02
Katherine Rubenstein departed her role as Chief Operating Officer of Blackstone Secured Lending Fund on June 15, 2026, to pursue other opportunities. The disclosure explicitly states this was not due to any disagreement with the Fund's operations or policies. This is a straightforward executive departure of a named officer, material to investors assessing the Fund's management continuity and operational leadership.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-18
Item 5.02
Katherine Rubenstein departed her role as Chief Operating Officer of Blackstone Private Credit Fund on June 15, 2026. The disclosure explicitly states her departure was not due to disagreement with the Fund's operations or policies. This is a straightforward executive departure of a named officer, filed under Item 5.02, and is material as it involves a senior operational executive leaving the organization.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-18
Item 1.01
SS Innovations entered into an ATM Sales Agreement with Virtu Americas LLC on June 18, 2026, to sell up to $50 million of common stock through an "at the market offering" program. This is a classic dilutive equity issuance that would materially affect existing shareholders through potential dilution and is a significant capital-raising activity for the company.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-06-18
Item 5.02
The filing discloses the resignation of three directors (Meghji, Fader-Rattner, Perkal) and three principal officers effective June 18, 2026: CEO Robert Rivas Collins, CFO Eric Greenhaus, and COO Matthew Perkal. While the filing also includes appointments of Chinh Chu as principal executive officer and Thomas Boychuk as CFO, the dominant narrative centers on the departures of key leadership. The simultaneous departure of the CEO, CFO, and COO, along with three board members, represents a material change in control and governance structure that would affect a reasonable investor's assessment of the company.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-18
Palmer Square Capital BDC Inc. disclosed the pricing of a $300 million term debt securitization refinancing (CLO Reset Transaction) through its subsidiary Palmer Square BDC CLO 1, Ltd., expected to close July 15, 2026. While technically a refinancing rather than a traditional M&A transaction, this represents a material capital structure event involving the issuance of $228 million AAA Class A Notes and $72 million AA Class B Notes, which materially affects the company's financing obligations and capital structure. The transaction is disclosed under Item 7.01 (Regulation FD Disclosure) rather than a dedicated M&A item, but the substance—a significant debt refinancing affecting the company's financial position—qualifies as material activity.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-18
EX-99.1
INLIF announces a strategic entry into the humanoid robotics market, representing a material expansion of the company's business scope beyond its traditional injection molding machine manipulator arms. The announcement discloses R&D commencement in H1 2026, prototype testing with claimed high-dynamic motion capabilities, and four strategic initiatives for commercialization.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-18
EX-99.2
INLIF announces completion of delivery and commercial acceptance of its first order of battery cell packing machines worth approximately $4.4 million USD (RMB 30 million), along with a follow-on order for six additional units and management's estimate of up to 50 units by end-2026 (approximately $14.7 million), representing a material operational and strategic milestone in the company's transition into industrialization of new energy equipment.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-18
Item 1.01
Cantor Equity Partners VII, Inc. completed a $250 million initial public offering on June 18, 2026, entering into multiple material definitive agreements including an underwriting agreement, business combination marketing agreement, and sponsor agreements. This represents a material capital-raising event and change of control structure typical of blank-check company (SPAC) formations.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-18
Item 3.02
The Company completed an unregistered private placement of 600,000 Class A Ordinary Shares to the Sponsor at $10.00 per share ($6 million gross proceeds) pursuant to Section 4(a)(2) of the Securities Act, simultaneously with the IPO closing. This is a material dilutive issuance typical of SPAC sponsor equity stakes.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 5.03
The Company filed Amended and Restated Memorandum and Articles of Association effective June 17, 2026, in connection with the completion of its $250 million IPO. While the governing document amendment itself is administrative, the IPO context makes this structural formalization material to investors.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-18
EX-99.1
IceCure announced 70% growth in its U.S. commercial install base for ProSense® breast cancer cryoablation systems following FDA clearance in October 2025, driven by increased physician demand and clinical guideline support from the American Society of Breast Surgeons.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-18
EX-99.2
IceCure completed a $5.5 million private placement of 1,833,334 ordinary shares plus Series D and E Warrants to a healthcare-focused institutional investor at $3.00 per share, issued under Section 4(a)(2) exemption.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-06-18
EX-99.1
Akanda received a Nasdaq notice on June 16, 2026 indicating non-compliance with Listing Rule 5550(b)(1) due to stockholders' equity of negative $11.99 million, falling below the required $2.5 million minimum. The company has 45 days to submit a compliance plan or face delisting. This is a direct notice of failure to satisfy a continued listing rule, the defining characteristic of delisting_risk.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-06-18
The 6-K discloses entry into a Share Purchase Agreement on June 17, 2026, whereby Ohmyhome Limited agreed to sell all shares in its wholly-owned subsidiary Ohmyhome BVI to Sterling Oat Ltd for $1, with the transaction closing on May 31, 2026. This constitutes a material disposition of a business segment (real estate brokerage and property-related services in Singapore and Malaysia). The Board approved the divestiture after evaluating declining revenues and operating losses, and the company is exiting this business to focus on digital marketing services. The waiver of SGD 19 million in subsidiary debt immediately preceding the sale is a related financing restructuring to facilitate the disposition.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-18
Item 8.01
The filing discloses a registered public offering of 38,333,333 shares of common stock (including full exercise of the underwriter's over-allotment option) generating approximately $63.25 million in gross proceeds. This is a material dilutive equity issuance that would significantly affect a reasonable investor's assessment of ownership dilution and the company's capital structure. The offering was conducted pursuant to an effective Form S-1 registration statement, making this a registered public offering rather than an unregistered private placement.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-06-18
Item 8.01
The Company received a notice from NYSE American on May 27, 2026, indicating non-compliance with continued listing standards under Section 1003(a)(ii) of the NYSE American Company Guide due to insufficient stockholders' equity ($4.0 million minimum required) combined with losses in three of four recent fiscal years. The June 18, 2026 submission of a compliance plan is a direct response to delisting risk and represents a material disclosure of failure to satisfy a continued listing rule.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-18
Item 2.03
Item 3.02 discloses an unregistered private placement of a Pre-Funded Warrant to Tether issued on June 18, 2026 as consideration for transfer of 50% of a receivable under an existing loan. The warrant was issued without Securities Act registration under Section 4(a)(2) and Regulation D Rule 506(b) exemptions, representing a dilutive equity issuance to an accredited investor. This is a material capital structure event affecting shareholder equity.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-06-18
Item 8.01
The filing discloses that Silo Pharma has regained compliance with Nasdaq Listing Rule 5550(a)(2) minimum bid price requirement after previously falling out of compliance in June 2025. While the current disclosure is positive (compliance restored), the underlying event—a delisting risk triggered by failure to maintain the $1.00 minimum bid price—is material to investors' assessment of the company's listing status and market viability. The company explicitly references the prior non-compliance letter and confirms that Nasdaq "considers this matter closed," indicating resolution of a previously disclosed delisting threat.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-18
Item 5.02
The disclosure centers on the departure of David Kronenfeld, the Company's general counsel, effective August 7, 2026, pursuant to a transition and separation agreement. While the filing details severance payments and accelerated vesting of restricted stock units, the principal disclosed action is the executive's departure from his role. The material nature is evident from the severance package value (cash, benefits, and equity acceleration totaling substantial consideration) and the executive's position as general counsel.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-18
Item 5.02
James Cabral ceased serving as Chief Operating Officer effective June 16, 2026, and is no longer employed by the Company. This is a clear departure of a named executive officer from a material position. The filing explicitly states the departure was not due to disagreement, but the event itself—loss of a COO—is material to investors assessing management continuity and operational leadership.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-18
EX-99.1
The press release announces a private placement of $6.5 million in ordinary shares (or pre-funded warrants) and ordinary warrants to accredited and institutional investors under Section 4(a)(2) and Regulation D exemptions. This is an unregistered equity issuance that will dilute existing shareholders, with 1,857,143 ordinary shares and accompanying warrants being issued at $3.50 per share. The company explicitly states it has entered into definitive securities purchase agreements and expects closing on June 23, 2026.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-18
Item 5.07
Shareholders approved an Extension Amendment at an extraordinary general meeting on June 18, 2026, extending the business combination deadline from June 20, 2026 to March 20, 2027, with 15,786,622 votes in favor, 1,468,989 against, and 400,036 abstentions.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-06-18
Item 8.01
The Sponsor converted 3,000,000 Class B ordinary shares into Class A ordinary shares pursuant to the Company's Amended and Restated Memorandum and Articles of Association, materially affecting the capital structure and relative voting power of shareholders.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 97%
filed 2026-06-18
Item 5.07
Live Oak Acquisition Corp. V shareholders voted at an extraordinary general meeting on June 16, 2026, approving all 14 proposals by substantial majorities, including the business combination with Teamshares, domestication, charter amendments, equity incentive plans, Nasdaq listing approval, director elections, and an insider letter amendment. The approval clears the path for the transaction to close.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-18
Item 8.01
The disclosure announces the completion of a 20-million-unit IPO on May 4, 2026, and the subsequent separation of units into Class A Ordinary Shares and Warrants for trading on NYSE under symbols "QLEP" and "QLEP WS" commencing June 23, 2026. While this is a material capital-raising event, it does not fit neatly into the standard taxonomy: it is neither a traditional earnings release, M&A activity, nor a governance event. The IPO completion and unit separation are significant financial and operational milestones for a blank-check company, warranting classification as a material event outside the defined categories.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 85%
filed 2026-06-18
The disclosure announces the planned appointment of Mr. Yasunari Harada as Chief Financial Officer and director in Q3 2026, subject to board approval. Although the filing also mentions Mr. Raymond Chung's concurrent resignation, the principal disclosed action is the appointment of a new CFO with 30+ years of senior financial experience at global institutions. This is a material executive appointment affecting the registrant's financial leadership.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 94%
filed 2026-06-18
Item 1.01
Hyperscale Data entered into an At-the-Market (ATM) Issuance Sales Agreement on June 18, 2026, to sell up to $300 million of Class A common stock through Spartan Capital Securities. The offering is a registered equity issuance that will be dilutive to existing shareholders' ownership percentages and voting power, with proceeds earmarked for facility development, Bitcoin acquisition, and precious metals purchases.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 99%
filed 2026-06-18
Item 5.07
This Item 5.07 disclosure reports the final voting results from WisdomTree's June 17, 2026 Annual Meeting of Stockholders, certified by the independent inspector of election. The filing details results for three proposals: election of nine directors, ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with overwhelming majorities (97.39%–99.95% for director elections, 99.24% for auditor ratification, and 98.66% for compensation approval).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder voting results from Hercules Capital's 2026 Annual Meeting of Stockholders held on June 18, 2026. The filing presents detailed vote tallies for six proposals including director election, executive compensation advisory votes, equity plan amendments, and auditor ratification. Item 5.07 is the designated 8-K item for shareholder vote results, and the prose explicitly states voting outcomes with vote counts for each proposal.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 85%
filed 2026-06-18
The filing announces a partial mandatory redemption of 576,923 Class "C" preferred shares (0.0951% of outstanding PNC Shares) valued at R$30,000,000, approved by the Board on June 13, 2026, with an effective redemption date of July 7, 2026 at R$52.00 per share. This is a return of capital to preferred shareholders, functionally equivalent to a dividend or distribution. While the document also discusses tax implications and optional conversion rights, the core disclosure is the mandatory redemption and cash distribution to shareholders.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 95%
filed 2026-06-18
The 6-K furnishes minutes of TIM S.A.'s Fiscal Council meeting held June 17, 2026, documenting approval of a distribution of Interest on Shareholders' Equity (IE) in the amount of R$400,000,000 (approximately $0.1674573219 per share), payable by July 22, 2026, with an ex-dividend date of June 22, 2026. This is a material capital distribution to shareholders that would affect a reasonable investor's assessment of the company's capital allocation and cash position.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-06-18
The 6-K furnishes minutes of a Board of Directors meeting held June 17, 2026, disclosing multiple governance actions: (1) acknowledgment of Control and Risks Committee and Statutory Audit Committee activities, including ISO 37001 anti-bribery certification; (2) approval of amendments to the Related Parties Transactions Policy; (3) approval of R$400 million interest-on-equity distribution to shareholders; (4) election of Luciene Rodrigues Abrão Pandolfo as Legal Officer and composition of the Board of Officers; and (5) ratification of officer appointments in subsidiaries. While the dividend distribution is material, the primary substance of the filing is governance-focused board actions (policy amendments, officer elections, committee acknowledgments) that do not fit a single discrete event type. The appointment of a new Legal Officer is disclosed but is secondary to the broader governance agenda. Classified as governance_other because the filing is clearly governance-domain but comprises multiple routine board resolutions rather than a single named event.
View raw filing on EDGAR →